Quarterly report · Q2
4503.TEDINET S100PH6Y
Period2022-04-01 → 2022-09-30
Filed2022-11-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥762.2bn | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥380.4bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥1.30T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥651.7bn | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥325.5bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥119.9bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥86.7bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥90.2bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥54.1bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥120.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥88.8bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥156.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥89.1bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥53.3bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥96.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥71.6bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥124.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥71.6bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥40.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥96.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥71.6bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥71.6bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥40.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥2.58T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥2.33T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥2.26T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥934.1bn | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥872.1bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.65T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.46T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.42T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.39T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.65T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.42T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥361.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥316.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥318.3bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥326.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥139.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥257.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥139.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥34.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥62.4bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥55.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥81.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥216.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥89.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.87 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥39.3 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥67.08 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥38.65 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥22.09 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥52.85 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥39.28 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥67.05 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥38.63 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.08 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 63.8% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.7% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 695
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf IFRS | CurrentYTDDuration | -13795000000 | JPY |
| Purchase of intangible assets inv cf IFRS | Prior1YTDDuration | -30382000000 | JPY |
| Purchase of intangible assets inv cf IFRS | CurrentYTDDuration | -25894000000 | JPY |
| Proceeds from sale of intangible assets inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from sale of intangible assets inv cf IFRS | CurrentYTDDuration | 172000000 | JPY |
| Proceeds from sale of equity instruments inv cf IFRS | Prior1YTDDuration | 443000000 | JPY |
| Proceeds from sale of equity instruments inv cf IFRS | CurrentYTDDuration | 12104000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1YTDDuration | -649000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | CurrentYTDDuration | － | JPY |
| Interest and dividends received inv cf IFRS | Prior1YTDDuration | 292000000 | JPY |
| Interest and dividends received inv cf IFRS | CurrentYTDDuration | 1022000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | -7955000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -8268000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -55744000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -34660000000 | JPY |
| Increase decrease in bonds and short term borrowings fin cf IFRS | Prior1YTDDuration | -40000000000 | JPY |
| Increase decrease in bonds and short term borrowings fin cf IFRS | CurrentYTDDuration | -15000000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -715000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -10553000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | Prior1YTDDuration | -38914000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | CurrentYTDDuration | -45677000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -9083000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -8853000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | -1224000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | -1348000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -89936000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -81431000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | -1539000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 21321000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | -7834000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 45087000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 326128000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 315986000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 318295000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 361073000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-11-08 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第18期第２四半期 (自 2022年７月１日 至 2022年９月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)アステラス製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | Astellas Pharma Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 安川 健司 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋本町二丁目５番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03 (3244) 3000 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)財務戦略 決算グループリーダー 大久保 伸 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋本町二丁目５番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03 (3244) 3000 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務戦略 決算グループリーダー 大久保 伸 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |